Trevena
TRVN
$0.39
Share price
-4.40%
Change (1 day)
-39.85%
Change (1 year)
Categories
Trevena (TRVN) - Cash on Hand
Cash on Hand as of September 2023 : $34.95 M
According to Trevena's latest financial reports the company has $34.95 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Trevena - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $38.32 M | -42.74% |
| 2021-12-31 | $66.92 M | -38.83% |
| 2020-12-31 | $0.10 B | 205.55% |
| 2019-12-31 | $35.8 M | -41.76% |
| 2018-12-31 | $61.48 M | -6.99% |
| 2017-12-31 | $66.1 M | -40.24% |
| 2016-12-31 | $0.11 B | -35.93% |
| 2015-12-31 | $0.17 B | 61.49% |
| 2014-12-31 | $0.10 B | 181.58% |
| 2013-12-31 | $37.96 M | 463.39% |
| 2012-12-31 | $6.73 M | -60.5% |
| 2011-12-31 | $17.06 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $10.94 B | 31,211.51% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 20,193.55% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Cytokinetics
CYTK | $0.61 B | 1,659.05% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $9.38 M | -73.16% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $0.10 B | 188.28% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |